Navigation Links
Schizophrenia linked to dysfunction in molecular brain pathway activated by marijuana
Date:7/7/2008

PITTSBURGH, July 7 Alterations in a molecular brain pathway activated by marijuana may contribute to the cognitive symptoms of schizophrenia, according to a report in the July issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

Expression of the cannabinoid 1 receptor (CB1R), the site of action of the main chemical ingredient of marijuana, is significantly reduced in the brains of individuals with schizophrenia. Activation of CB1R impairs signaling by gamma-aminobutyric acid (GABA), an important neurotransmitter essential for core cognitive processes such as working memory. The use of marijuana in individuals with schizophrenia appears to worsen this deficit in GABA synthesis.

Since reduced GABA is known to be present in schizophrenia, these findings suggest possible new drug targets that could help to improve function in people with the mental illness, University of Pittsburgh School of Medicine researchers report.

"Heavy marijuana use, particularly in adolescence, appears to be associated with an increased risk for the later development of schizophrenia, and the course of illness is worse for people with schizophrenia who use marijuana," said David A. Lewis, M.D., corresponding author of the study and UPMC Endowed Professor in Translational Neuroscience, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine. "We wanted to understand the biological mechanisms that could explain these observations, and with this study, I believe that we can narrow down at least part of the 'why' to CB1R, the receptor for both tetrahydrocannabinol (THC), the main psychoactive ingredient in marijuana, and the brains own cannabinoid chemical messengers."

Dr. Lewis and his colleagues examined specimens of brain tissue collected after death from 23 people with schizophrenia and 23 normal comparison subjects matched for a number of factors, including age and sex. The researchers evaluated levels of CB1R messenger RNA and protein, and also measured levels of glutamic acid decarboxylase (GAD-67), an enzyme that makes GABA, and cholecystokinin (CCK), a neuropeptide released from GABA neurons that, among other actions, regulates the production of the brain's own cannabinoids.

"CB1R levels were significantly 15 percent lower in the subjects with schizophrenia," Dr. Lewis said. "We measured these biochemical messengers using three techniques, and each time got the same answer less CB1R in people with schizophrenia." This reduction, he noted, appears to be the brain's way of compensating for lower levels of GABA, and the use of marijuana defeats this compensation.

"These findings may provide insight into the biological basis of why cannabis use worsens schizophrenia, and, as a result, identify a novel target for new drug development that could improve treatments available for schizophrenia," said Dr. Lewis.


'/>"/>

Contact: Michele Baum
BaumMD@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Related medicine news :

1. Violence declines with medication use in some with schizophrenia
2. Brain Activity May Predict Schizophrenia Behavior
3. Hopkins researchers discover new link to schizophrenia
4. Dr. Mei honored by mental health research charity for schizophrenia studies
5. Schizophrenia: Diagnosis Is Not Destiny - Conference
6. New Drugs No Better Than Older Ones for Schizophrenia
7. Schizophrenia Tied to Multiple Genetic Errors
8. Comparison of antipsychotic treatments in adolescents with schizophrenia
9. New genetic association with schizophrenia found by researchers
10. FDA Issues Not-Approvable Letter for Lillys Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
11. Siblings of schizophrenia patients display subtle shape abnormalities in brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2017)... Atlanta, GA (PRWEB) , ... May 19, 2017 , ... ... D. Miller knows the importance of prostate cancer screenings. Early detection of the ... Miller, head of robotic surgery at Georgia Urology , stands alongside the Georgia ...
(Date:5/19/2017)... ... May 18, 2017 , ... CloSYS products which are marketed ... while extremely helpful for mouth and gum health, which is linked to one’s overall ... customers learned quickly of the powerful ways in which CloSYS products immediately helped eliminate ...
(Date:5/19/2017)... ... May 18, 2017 , ... Somnoware, a leading provider of ... physicians to independently dispense CPAP devices and supplies, such as machines, filters, tubing, and ... dispense the devices. Device registration for daily usage data is automated, and a DME ...
(Date:5/18/2017)... ... May 18, 2017 , ... Originally launched to market as the ... Tab. Due to the rapid expansion of their product line, the company believed it ... Now, the HighQ brand will be any tablet product sold by EPIK Learning. ...
(Date:5/18/2017)... ... May 18, 2017 , ... ... VA based educational and charitable organization which sponsors numerous programs and activities aimed ... MURPH Challenge event over Memorial Day Weekend. , The MURPH Challenge, named ...
Breaking Medicine News(10 mins):
(Date:5/6/2017)... , May 5, 2017  Hill-Rom Holdings, Inc. ... add approximately 100,000 square feet to its Welch Allyn ... 2016 its commitment to bring more than 100 new ... where Welch Allyn has maintained a significant presence for ... accommodate these new positions, a large portion of which ...
(Date:5/4/2017)... LAWRENCE, Mass. and SAN DIEGO ... of Obstetricians and Gynecologists (ACOG) 2017 Annual Clinical and ... of single-use, self-contained, illuminating medical devices, today announced the ... size of its OfficeSPEC and ER-SPEC ... large, the addition of extra-small and extra-large sizes makes ...
(Date:5/3/2017)... , May 3, 2017 A ... any hospital or healthcare facility. Commonly referred to ... is equipped with diagnostic imaging technology to give ... the heart. In these spaces, a team of ... balloon angioplasty, percutaneous coronary intervention, congenital heart defect ...
Breaking Medicine Technology: